3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Recurrence
3
Hematologic Neoplasms
3
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Solid Tumors Harboring NTRK Fusion
1
Skin Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Mastocytosis, Systemic
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Locally Advanced Solid Tumors
1
Leukemia, Myeloid, Acute
1
Leukemia, Mast-Cell
1
Head and Neck Neoplasms
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
entrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Has announcements
×
Locally Advanced Solid Tumors
×
Clear all
NCT02097810
2021-06-09
STARTRK-1
Hoffmann-La Roche
Phase 1
Completed
84 enrolled
1 FDA